SEC Form 4 · accession 0001127602-19-003368
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter K Shagory
Officer — EVP, STRAT & CORP DEVT
Period of report
Jan 31, 2019
Accepted (ET)
Feb 1, 2019 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 31, 2019 | M | 4,000 | $39.87 | A | 5,155 | D | |
| Common StockF1 | Jan 31, 2019 | S | 4,000 | $69.29 | D | 1,155 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options To Purchase Common StockF2,F3 | $39.87 | Jan 31, 2019 | M | 4,000 | D | — | Mar 1, 2026 | Common Stock | 4,000 | 15,700 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.21 to $69.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- F2Options exercised pursuant to carve out in Lock-Up Agreement.
- F3The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period